Evidence map›Paper›PMID 25924890›Full record

ArticleJournal of medical case reports2015

Orbital dermatofibrosarcoma protuberans with intracranial extension preceded by recurrent leiomyoma of the orbit: a case report.

Sanaullah Bashir, Maryam Tariq, Hafiz Muhammad Aslam, Abdul Sattar M Hashmi, Baber Malik, Akhtar Amin, Sidra Mumtaz

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Dermatofibrosarcoma protuberans of the upper eyelid treated with surface mould high-dose-rate brachytherapy.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sanaullah BashirDow Medical College, Dow University of Health Sciences, Karachi, Pakistan. sanaullahbashir@gmail.com.
Maryam TariqDow Medical College, Dow University of Health Sciences, Karachi, Pakistan. mariamtariq27@hotmail.com.
Hafiz Muhammad AslamDow Medical College, Dow University of Health Sciences, Karachi, Pakistan. coolaslam8@hotmail.com.
Abdul Sattar M HashmiDepartment of Neurosurgery, Jinnah Postgraduate Medical Center, Karachi, Pakistan. neurospi@cyber.net.pk.
Baber MalikDepartment of Molecular Diagnostic and Immunology Laboratory, Sindh Institute of Urology and Transplantation, Aga Khan University, Karachi, Pakistan. babarmalik@msn.com.
Akhtar AminDow Medical College, Dow University of Health Sciences, Karachi, Pakistan. akhtar.amin@live.com.
Sidra MumtazDow Medical College, Dow University of Health Sciences, Karachi, Pakistan. muneera_iman@hotmail.com.
Dow University of Health Sciences · PKAga Khan University · PKJinnah Postgraduate Medical Center · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDermatofibrosarcoma protuberans is a rare, locally aggressive cutaneous tumor of intermediate to low-grade malignancy. COL1A1-PDGFβ translocation is specific to dermatofibrosarcoma protuberans, where the abnormally fused COL1A1-PDGFβ gene directs formation of an abnormal combined (fusion) protein that researchers believe to ultimately function like the platelet-derived growth factor-beta protein. CASE PRESENTATION: In this report, we present a case of a 63-year-old Asian man with dermatofibrosarcoma protuberans of the right orbit with intracranial extension. He had a prior history of recurrent leiomyomas at the identical site. He underwent near-total en bloc resection of the tumor through a wide craniectomy with a 6 cm rim of the frontal scalp, allowing the tumor to be resected en bloc, leaving negative margins. Microscopically, the tumor comprised spindle cells with mild nuclear atypia and a low mitotic index embedded in a spiraling pattern of decussating fascicles consistent with dermatofibrosarcoma protuberans. The lesion was positive for CD34 and BCL2. Following resection, the patient was started on imatinib mesylate therapy (800 mg/day).

conclusionsWe propose that platelet-derived growth factor, which has been implicated in the progression of leiomyomas by augmenting mitogenesis, may have acted in an autocrine manner to cause cell division, which may have led to the development of dermatofibrosarcoma protuberans in our patient. Further research is imperative to find certain molecular associations between the discussed soft tissue tumors. Also important is the effective utilization of platelet-derived growth factor receptor kinase inhibitors to prevent transformation to any platelet-derived growth factor-driven tumor, which in our patient was a dermatofibrosarcoma protuberans.

Indexed as

Antineoplastic AgentsCell Transformation, NeoplasticCombined Modality TherapyDermatofibrosarcomaEye NeoplasmsHumansImatinib MesylateLeiomyomaMaleMiddle AgedOncogene Proteins, FusionOrbitSkin NeoplasmsAntineoplastic AgentsCOLIA1-PDGFB fusion protein, humanImatinib MesylateOncogene Proteins, Fusion

Identifiers

PMID25924890
PMCPMC4423146
OpenAlexW1990406784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.